Drug Profile
Research programme: hepatitis C virus vaccine - Merck & Co
Latest Information Update: 24 Jan 2008
Price :
$50
*
At a glance
- Originator Merck & Co
- Class
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hepatitis C